[
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 241,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "setid=e0fa4bca-f245-4d92-ae29-b0c630a315c2",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0fa4bca-f245-4d92-ae29-b0c630a315c2"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1201827",
    "parent_molecule_chembl_id": "CHEMBL1201827",
    "record_id": 1390843,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 242,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "setid=8bc6397e-4bd8-4d37-a007-a327e4da34d9",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bc6397e-4bd8-4d37-a007-a327e4da34d9"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1201577",
    "parent_molecule_chembl_id": "CHEMBL1201577",
    "record_id": 1344036,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 243,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "setid=57bccb29-1c47-4c64-ab6a-77960a91cc20#section-13",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57bccb29-1c47-4c64-ab6a-77960a91cc20#section-13"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1079742",
    "parent_molecule_chembl_id": "CHEMBL553",
    "record_id": 1344174,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 244,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL939",
    "parent_molecule_chembl_id": "CHEMBL939",
    "record_id": 1344994,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 245,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "setid=63319b01-cad6-4d0a-c39b-938fa951a808#section-13",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63319b01-cad6-4d0a-c39b-938fa951a808#section-13"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1201179",
    "parent_molecule_chembl_id": "CHEMBL554",
    "record_id": 1343218,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 2234,
    "mechanism_comment": "Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "fd638e5e-8032-e7ca-0179-95e96ab5d387",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2105712",
    "parent_molecule_chembl_id": "CHEMBL1173655",
    "record_id": 1702610,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 2424,
    "mechanism_comment": "Binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion)",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7"
      },
      {
        "ref_id": "24893891",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/24893891"
      },
      {
        "ref_id": "25271963",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/25271963"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3545063",
    "parent_molecule_chembl_id": "CHEMBL3353410",
    "record_id": 2472960,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 2427,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "setid=89bcf553-669a-40b0-a9d7-67a5c1d2f591",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89bcf553-669a-40b0-a9d7-67a5c1d2f591"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1743047",
    "parent_molecule_chembl_id": "CHEMBL1743047",
    "record_id": 1392931,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4100,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "17062696",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/17062696"
      },
      {
        "ref_id": "19821562",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/19821562"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1645462",
    "parent_molecule_chembl_id": "CHEMBL1645462",
    "record_id": 2473187,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4126,
    "mechanism_comment": "Irreversible inhibitor, also potent at ERBB4.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "21789172",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/21789172"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1947204",
    "parent_molecule_chembl_id": "CHEMBL1947204",
    "record_id": 2473340,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4137,
    "mechanism_comment": "No further data/studies for the compound found.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "http://adisinsight.springer.com/drugs/800024847",
        "ref_type": "Other",
        "ref_url": "http://adisinsight.springer.com/drugs/800024847"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL422872",
    "parent_molecule_chembl_id": "CHEMBL422872",
    "record_id": 2473760,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4162,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "11178955",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/11178955"
      },
      {
        "ref_id": "15199094",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/15199094"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL258940",
    "parent_molecule_chembl_id": "CHEMBL258940",
    "record_id": 2473091,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4179,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf",
        "ref_type": "Other",
        "ref_url": "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2029988",
    "parent_molecule_chembl_id": "CHEMBL2029988",
    "record_id": 2473489,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4198,
    "mechanism_comment": "Inhibits class I (HDAC1 HDAC2 HDAC3 HDAC8) and II (HDAC4 HDAC5 HDAC6 HDAC7 HDAC9 HDAC10) HDACs",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "20143778",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/20143778"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL598797",
    "parent_molecule_chembl_id": "CHEMBL598797",
    "record_id": 2473346,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 4231,
    "mechanism_comment": "EGFR mutant selective including both activating mutations and T790M (PMID: 26508839). Covalent binder (PMID: 27357069).",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "http://www.hanmipharm.com/ehanmi/img/rnd/2013_WCLC_(HM61713).pdf",
        "ref_type": "Other",
        "ref_url": "http://www.hanmipharm.com/ehanmi/img/rnd/2013_WCLC_(HM61713).pdf"
      },
      {
        "ref_id": "26508839",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/26508839"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3786343",
    "parent_molecule_chembl_id": "CHEMBL3786343",
    "record_id": 2795535,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4236,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02601248",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02601248"
      },
      {
        "ref_id": "http://www.hmplglobal.com/en/theliatinibhmpl-309/",
        "ref_type": "Other",
        "ref_url": "http://www.hmplglobal.com/en/theliatinibhmpl-309/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL5314410",
    "parent_molecule_chembl_id": "CHEMBL5314410",
    "record_id": 2473193,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4238,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02590952",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02590952"
      },
      {
        "ref_id": "http://www.hmplglobal.com/en/epitinib-hmpl-813/",
        "ref_type": "Other",
        "ref_url": "http://www.hmplglobal.com/en/epitinib-hmpl-813/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL5314411",
    "parent_molecule_chembl_id": "CHEMBL5314411",
    "record_id": 2473058,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4240,
    "mechanism_comment": "Multi-targeted tyrosine kinase inhibitor",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "10.1016/S1359-6349(10)71870-X",
        "ref_type": "DOI",
        "ref_url": "http://www.sciencedirect.com/science/article/pii/S135963491071870X"
      },
      {
        "ref_id": "20823884",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/20823884"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3109738",
    "parent_molecule_chembl_id": "CHEMBL3109738",
    "record_id": 2473117,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4288,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "17888033",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/17888033"
      },
      {
        "ref_id": "19459856",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/19459856"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL6067986",
    "parent_molecule_chembl_id": "CHEMBL2138625",
    "record_id": 2472853,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4306,
    "mechanism_comment": "Multi-targeted kinase irreversible inhibitor",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "10638483",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/10638483"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3545196",
    "parent_molecule_chembl_id": "CHEMBL49120",
    "record_id": 2473264,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4320,
    "mechanism_comment": "Also potent against ABL1",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "10850439",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/10850439"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1963502",
    "parent_molecule_chembl_id": "CHEMBL1963502",
    "record_id": 2473125,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4366,
    "mechanism_comment": "Also potent ERBB4 inhibitor",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "24837299",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/24837299"
      },
      {
        "ref_id": "25434923",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/25434923"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3545200",
    "parent_molecule_chembl_id": "CHEMBL3545200",
    "record_id": 2473271,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4386,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "10.1016/S1359-6349(08)72245-6",
        "ref_type": "DOI",
        "ref_url": "http://www.sciencedirect.com/science/article/pii/S1359634908722456"
      },
      {
        "ref_id": "22003817",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/22003817"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL1614725",
    "parent_molecule_chembl_id": "CHEMBL1614725",
    "record_id": 2472714,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 4488,
    "mechanism_comment": "Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "10.1158/1538-7445.AM2011-4245",
        "ref_type": "DOI",
        "ref_url": "http://cancerres.aacrjournals.org/content/71/8_Supplement/4245"
      },
      {
        "ref_id": "26499488",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/26499488"
      },
      {
        "ref_id": "26510909",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/26510909"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4545915",
    "parent_molecule_chembl_id": "CHEMBL4596972",
    "record_id": 2473005,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 4525,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "http://meetinglibrary.asco.org/content/146824-156",
        "ref_type": "Other",
        "ref_url": "http://meetinglibrary.asco.org/content/146824-156"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3647420",
    "parent_molecule_chembl_id": "CHEMBL3647420",
    "record_id": 2472761,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4611,
    "mechanism_comment": "Also potent inhibitor of SRC, ABL1 and CSF1R",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "15256466",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/15256466"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL587723",
    "parent_molecule_chembl_id": "CHEMBL587723",
    "record_id": 2473287,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 4623,
    "mechanism_comment": "Inhibits ALK and EGFR gatekeeper mutants. Does not inhibit wild type (native) EGFR.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "http://www.ariad.com/AP26113",
        "ref_type": "Other",
        "ref_url": "http://www.ariad.com/AP26113"
      },
      {
        "ref_id": "http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf",
        "ref_type": "Other",
        "ref_url": "http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf"
      },
      {
        "ref_id": "25888090",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/25888090"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3545311",
    "parent_molecule_chembl_id": "CHEMBL3545311",
    "record_id": 2473542,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4625,
    "mechanism_comment": "Also ERBB4 inhibitor",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf",
        "ref_type": "Other",
        "ref_url": "http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf"
      },
      {
        "ref_id": "http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/",
        "ref_type": "Other",
        "ref_url": "http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2103842",
    "parent_molecule_chembl_id": "CHEMBL2103842",
    "record_id": 1699831,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4651,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "20145185",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/20145185"
      },
      {
        "ref_id": "24900741",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/24900741"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2408045",
    "parent_molecule_chembl_id": "CHEMBL2408045",
    "record_id": 2473015,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4671,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "21531814",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/21531814"
      },
      {
        "ref_id": "24130056",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/24130056"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3545396",
    "parent_molecule_chembl_id": "CHEMBL3545396",
    "record_id": 2473712,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 4694,
    "mechanism_comment": "Irreversible inhibitor, EGFR T790M mutant selective",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "24723450",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/24723450"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3545308",
    "parent_molecule_chembl_id": "CHEMBL3545308",
    "record_id": 2473538,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 4713,
    "mechanism_comment": "Irreversible inhibitor",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "12502359",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/12502359"
      },
      {
        "ref_id": "15715478",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/15715478"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL607707",
    "parent_molecule_chembl_id": "CHEMBL607707",
    "record_id": 1705102,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 4853,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "http://kadmon.com/press/kadmon-corporation-presents-encouraging-nonclinical-data-on-tesevatinib-kd019-at-aacr-annual-meeting/",
        "ref_type": "Other",
        "ref_url": "http://kadmon.com/press/kadmon-corporation-presents-encouraging-nonclinical-data-on-tesevatinib-kd019-at-aacr-annual-meeting/"
      },
      {
        "ref_id": "17575237",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/17575237"
      },
      {
        "ref_id": "22173702",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/22173702"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3544983",
    "parent_molecule_chembl_id": "CHEMBL3544983",
    "record_id": 2473100,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 5179,
    "mechanism_comment": "EGF816 is an irreversible TKI that demonstrates selectivity for mutant EGFRs compared with WT EGFR and targets activating and resistance mutations with equal potency (doi: 10.1158/1538-7445.AM2014-1734).",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02108964",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02108964"
      },
      {
        "ref_id": "10.1158/1538-7445.AM2014-1734",
        "ref_type": "DOI",
        "ref_url": "http://cancerres.aacrjournals.org/content/74/19_Supplement/1734"
      },
      {
        "ref_id": "31954624",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/31954624/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3787344",
    "parent_molecule_chembl_id": "CHEMBL3787344",
    "record_id": 2473324,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 5260,
    "mechanism_comment": "Binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion)",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7",
        "ref_type": "DailyMed",
        "ref_url": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7"
      },
      {
        "ref_id": "24893891",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/24893891"
      },
      {
        "ref_id": "25271963",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/25271963"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3353410",
    "parent_molecule_chembl_id": "CHEMBL3353410",
    "record_id": 2473534,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 5277,
    "mechanism_comment": "Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "11706399",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/11706399"
      },
      {
        "ref_id": "12648472",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/12648472"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL545315",
    "parent_molecule_chembl_id": "CHEMBL31965",
    "record_id": 1702340,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 5285,
    "mechanism_comment": "Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "label/2017/208051s000lbl.pdf",
        "ref_type": "FDA",
        "ref_url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf"
      },
      {
        "ref_id": "15715478",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/15715478"
      },
      {
        "ref_id": "26089701",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/26089701"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL180022",
    "parent_molecule_chembl_id": "CHEMBL180022",
    "record_id": 1706035,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 5311,
    "mechanism_comment": "Dacomitinib is an irreversible pan-ERBB inhibitor.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf",
        "ref_type": "Other",
        "ref_url": "https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf"
      },
      {
        "ref_id": "18089823",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/18089823"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2105719",
    "parent_molecule_chembl_id": "CHEMBL2110732",
    "record_id": 1702618,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 5330,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "24440798",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/24440798"
      },
      {
        "ref_id": "24522198",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/24522198"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3545235",
    "parent_molecule_chembl_id": "CHEMBL3545235",
    "record_id": 2473325,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "ANTAGONIST",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 5470,
    "mechanism_comment": "Effectively blocks EGF-R signaling, and can potently induce Ab-dependent cell-mediated cytotoxicity (ADCC).",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 antagonist",
    "mechanism_refs": [
      {
        "ref_id": "15383606",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/15383606"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2107861",
    "parent_molecule_chembl_id": "CHEMBL2107861",
    "record_id": 1695941,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 6035,
    "mechanism_comment": "The binding of matuzumab to domain III sterically blocks the domain rearrangement that is required for high affinity ligand binding and receptor dimerization.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "18394559",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/18394559"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2108038",
    "parent_molecule_chembl_id": "CHEMBL2108038",
    "record_id": 1706874,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 6093,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "9191875",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/9191875"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2109390",
    "parent_molecule_chembl_id": "CHEMBL2109390",
    "record_id": 1706869,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "CROSS-LINKING AGENT",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 6094,
    "mechanism_comment": "Binds to the EGFR and to the high-affinity immunoglobulin G (IgG) receptor CD64 both separately and simultaneously. Mediates antibody-dependent cell-mediated cytotoxicity (ADCC) with lysis of EGFR overexpressing cell lines.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 cross-linking agent",
    "mechanism_refs": [
      {
        "ref_id": "17602224",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/17602224"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2109391",
    "parent_molecule_chembl_id": "CHEMBL2109391",
    "record_id": 1706871,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "ANTAGONIST",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 6096,
    "mechanism_comment": "Induces antibody-dependent cell-mediated cytotoxicity (ADCC).",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 antagonist",
    "mechanism_refs": [
      {
        "ref_id": "23209031",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/23209031"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2109389",
    "parent_molecule_chembl_id": "CHEMBL2109389",
    "record_id": 1706867,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 6345,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "19584289",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/19584289"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2108359",
    "parent_molecule_chembl_id": "CHEMBL2108359",
    "record_id": 1706877,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "ANTAGONIST",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 6346,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 antagonist",
    "mechanism_refs": [
      {
        "ref_id": "20068188",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/20068188"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2109388",
    "parent_molecule_chembl_id": "CHEMBL2109388",
    "record_id": 1706866,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "BINDING AGENT",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 6348,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 binding agent",
    "mechanism_refs": [
      {
        "ref_id": "28361465",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/28361465"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3707277",
    "parent_molecule_chembl_id": "CHEMBL3707277",
    "record_id": 2473143,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 6349,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "27843803",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/27843803"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3137345",
    "parent_molecule_chembl_id": "CHEMBL3137345",
    "record_id": 1706892,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 6350,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "28467975",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/28467975"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2109389",
    "parent_molecule_chembl_id": "CHEMBL2109389",
    "record_id": 1706867,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 7415,
    "mechanism_comment": "Dacomitinib is an irreversible pan-ERBB inhibitor.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf",
        "ref_type": "Other",
        "ref_url": "https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf"
      },
      {
        "ref_id": "18089823",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/18089823"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2110732",
    "parent_molecule_chembl_id": "CHEMBL2110732",
    "record_id": 2473074,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 7422,
    "mechanism_comment": "Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "label/2017/208051s000lbl.pdf",
        "ref_type": "FDA",
        "ref_url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf"
      },
      {
        "ref_id": "15715478",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/15715478"
      },
      {
        "ref_id": "26089701",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/26089701"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3989921",
    "parent_molecule_chembl_id": "CHEMBL180022",
    "record_id": 2973277,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "BINDING AGENT",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 7705,
    "mechanism_comment": "ErbB1-targeting MAB conjugated to a photosenstising dye.",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 binding agent",
    "mechanism_refs": [
      {
        "ref_id": "https://www.who.int/medicines/publications/druginformation/innlists/PL120.pdf",
        "ref_type": "Other",
        "ref_url": "https://www.who.int/medicines/publications/druginformation/innlists/PL120.pdf"
      },
      {
        "ref_id": "19707318",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/19707318"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4298088",
    "parent_molecule_chembl_id": "CHEMBL4298088",
    "record_id": 3460718,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 7766,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "32007598",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/32007598"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4297258",
    "parent_molecule_chembl_id": "CHEMBL4297258",
    "record_id": 3132824,
    "selectivity_comment": "Targets variant T790M and activating mutants",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 7799,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "26756222",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/26756222"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3786098",
    "parent_molecule_chembl_id": "CHEMBL3786098",
    "record_id": 3132563,
    "selectivity_comment": "Selective for T790M-containing EGFR",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 7802,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "25731184",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/25731184"
      },
      {
        "ref_id": "25761639",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/25761639"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3707294",
    "parent_molecule_chembl_id": "CHEMBL3707294",
    "record_id": 2583290,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 7803,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02349633",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02349633"
      },
      {
        "ref_id": "28287730",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/28287730"
      },
      {
        "ref_id": "31227004",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/31227004"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3989970",
    "parent_molecule_chembl_id": "CHEMBL3989970",
    "record_id": 2973328,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M,L858M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGMAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 7804,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "28954786",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/28954786"
      },
      {
        "ref_id": "29386539",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/29386539"
      },
      {
        "ref_id": "29807396",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/29807396"
      },
      {
        "ref_id": "31227004",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/31227004"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3663929",
    "parent_molecule_chembl_id": "CHEMBL3663929",
    "record_id": 2794876,
    "selectivity_comment": "Active against WT and variant EGFR. Increased activity against activating and resistance mutants vs. wild-type target.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 7962,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.5_suppl.59",
        "ref_type": "Other",
        "ref_url": "https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.5_suppl.59"
      },
      {
        "ref_id": "29464112",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/29464112"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4297842",
    "parent_molecule_chembl_id": "CHEMBL4297842",
    "record_id": 3133478,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8101,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "32007598",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/32007598"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4297258",
    "parent_molecule_chembl_id": "CHEMBL4297258",
    "record_id": 3132824,
    "selectivity_comment": "Targets variant T790M and activating mutants",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 8102,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "26313252",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/26313252"
      },
      {
        "ref_id": "27928026",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/27928026"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3623290",
    "parent_molecule_chembl_id": "CHEMBL3623290",
    "record_id": 3132462,
    "selectivity_comment": "Some selectivity for EGFR mutants over wild-type.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8143,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "32916310",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/32916310"
      },
      {
        "ref_id": "33656275",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/33656275"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4761468",
    "parent_molecule_chembl_id": "CHEMBL4761468",
    "record_id": 3461024,
    "selectivity_comment": "Targets EGFR with activating or T790M mutations.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8148,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "22112293",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/22112293"
      },
      {
        "ref_id": "22446631",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/22446631"
      },
      {
        "ref_id": "23586056",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/23586056"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2087361",
    "parent_molecule_chembl_id": "CHEMBL2087361",
    "record_id": 3131917,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8193,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02330367",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02330367"
      },
      {
        "ref_id": "https://mct.aacrjournals.org/content/15/11/2586.long",
        "ref_type": "Other",
        "ref_url": "https://mct.aacrjournals.org/content/15/11/2586.long"
      },
      {
        "ref_id": "https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/",
        "ref_type": "Other",
        "ref_url": "https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/"
      },
      {
        "ref_id": "https://www.sciencedirect.com/science/article/pii/S2590098620300221",
        "ref_type": "Other",
        "ref_url": "https://www.sciencedirect.com/science/article/pii/S2590098620300221"
      },
      {
        "ref_id": "27573423",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/27573423"
      },
      {
        "ref_id": "29392403",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/29392403"
      },
      {
        "ref_id": "32127939",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/32127939"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4297866",
    "parent_molecule_chembl_id": "CHEMBL4297865",
    "record_id": 3133506,
    "selectivity_comment": "Enhanced activity against 'activated' and T790M-type EGFR mutants",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8194,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02330367",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02330367"
      },
      {
        "ref_id": "https://mct.aacrjournals.org/content/15/11/2586.long",
        "ref_type": "Other",
        "ref_url": "https://mct.aacrjournals.org/content/15/11/2586.long"
      },
      {
        "ref_id": "https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/",
        "ref_type": "Other",
        "ref_url": "https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/"
      },
      {
        "ref_id": "https://www.sciencedirect.com/science/article/pii/S2590098620300221",
        "ref_type": "Other",
        "ref_url": "https://www.sciencedirect.com/science/article/pii/S2590098620300221"
      },
      {
        "ref_id": "27573423",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/27573423"
      },
      {
        "ref_id": "29392403",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/29392403"
      },
      {
        "ref_id": "32127939",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/32127939"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4297865",
    "parent_molecule_chembl_id": "CHEMBL4297865",
    "record_id": 3133504,
    "selectivity_comment": "Enhanced activity against 'activated' and T790M-type EGFR mutants",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8387,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "32916310",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/32916310"
      },
      {
        "ref_id": "33656275",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/33656275"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4761468",
    "parent_molecule_chembl_id": "CHEMBL4761468",
    "record_id": 3461024,
    "selectivity_comment": "Targets EGFR with activating or T790M mutations.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8410,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02330367",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02330367"
      },
      {
        "ref_id": "https://mct.aacrjournals.org/content/15/11/2586.long",
        "ref_type": "Other",
        "ref_url": "https://mct.aacrjournals.org/content/15/11/2586.long"
      },
      {
        "ref_id": "https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/",
        "ref_type": "Other",
        "ref_url": "https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/"
      },
      {
        "ref_id": "https://www.sciencedirect.com/science/article/pii/S2590098620300221",
        "ref_type": "Other",
        "ref_url": "https://www.sciencedirect.com/science/article/pii/S2590098620300221"
      },
      {
        "ref_id": "27573423",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/27573423"
      },
      {
        "ref_id": "29392403",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/29392403"
      },
      {
        "ref_id": "32127939",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/32127939"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4297866",
    "parent_molecule_chembl_id": "CHEMBL4297865",
    "record_id": 3133506,
    "selectivity_comment": "Enhanced activity against 'activated' and T790M-type EGFR mutants",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8440,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02330367",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02330367"
      },
      {
        "ref_id": "https://mct.aacrjournals.org/content/15/11/2586.long",
        "ref_type": "Other",
        "ref_url": "https://mct.aacrjournals.org/content/15/11/2586.long"
      },
      {
        "ref_id": "https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/",
        "ref_type": "Other",
        "ref_url": "https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/"
      },
      {
        "ref_id": "https://www.sciencedirect.com/science/article/pii/S2590098620300221",
        "ref_type": "Other",
        "ref_url": "https://www.sciencedirect.com/science/article/pii/S2590098620300221"
      },
      {
        "ref_id": "27573423",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/27573423"
      },
      {
        "ref_id": "29392403",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/29392403"
      },
      {
        "ref_id": "32127939",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/32127939"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4297865",
    "parent_molecule_chembl_id": "CHEMBL4297865",
    "record_id": 3133504,
    "selectivity_comment": "Enhanced activity against 'activated' and T790M-type EGFR mutants",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 8447,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02349633",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02349633"
      },
      {
        "ref_id": "28287730",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/28287730"
      },
      {
        "ref_id": "31227004",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/31227004"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3989970",
    "parent_molecule_chembl_id": "CHEMBL3989970",
    "record_id": 2973328,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 8448,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02349633",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02349633"
      },
      {
        "ref_id": "28287730",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/28287730"
      },
      {
        "ref_id": "31227004",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/31227004"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3989970",
    "parent_molecule_chembl_id": "CHEMBL3989970",
    "record_id": 2973328,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 8449,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "NCT02349633",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT02349633"
      },
      {
        "ref_id": "28287730",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/28287730"
      },
      {
        "ref_id": "31227004",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/31227004"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3989970",
    "parent_molecule_chembl_id": "CHEMBL3989970",
    "record_id": 2973328,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "L858R",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8505,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "22402607",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/22402607"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3678958",
    "parent_molecule_chembl_id": "CHEMBL3678958",
    "record_id": 3489941,
    "selectivity_comment": "Inhibits WT and L858R mutant EGFR. Also inhibits FYN, HCK, KDR, PDGFRβ, CSF1R, FGFR1 and FGFR2 with moderate activity.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "NEGATIVE ALLOSTERIC MODULATOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 1,
    "mec_id": 8539,
    "mechanism_comment": "Allosteric, irreversible, ATP competitive inhibitor",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 negative allosteric modulator",
    "mechanism_refs": [
      {
        "ref_id": "NCT04209465",
        "ref_type": "ClinicalTrials",
        "ref_url": "https://www.clinicaltrials.gov/ct2/show/NCT04209465"
      },
      {
        "ref_id": "https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS3665",
        "ref_type": "Other",
        "ref_url": "https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS3665"
      },
      {
        "ref_id": "https://investors.blackdiamondtherapeutics.com/news-releases/news-release-details/black-diamond-therapeutics-present-phase-1-bdtx-189-data",
        "ref_type": "Other",
        "ref_url": "https://investors.blackdiamondtherapeutics.com/news-releases/news-release-details/black-diamond-therapeutics-present-phase-1-bdtx-189-data"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4650279",
    "parent_molecule_chembl_id": "CHEMBL4650279",
    "record_id": 3490056,
    "selectivity_comment": "Selective for mutants vs. wild-type.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8591,
    "mechanism_comment": "Increased activity against EGFR mutants vs. wild-type",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "https://www.annalsofoncology.org/article/S0923-7534(20)41655-2/fulltext",
        "ref_type": "Other",
        "ref_url": "https://www.annalsofoncology.org/article/S0923-7534(20)41655-2/fulltext"
      },
      {
        "ref_id": "31467113",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/31467113"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4650281",
    "parent_molecule_chembl_id": "CHEMBL4650281",
    "record_id": 3490058,
    "selectivity_comment": "Increased activity against EGFR mutants vs. wild-type",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 8596,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "https://mct.aacrjournals.org/content/15/2/251",
        "ref_type": "Other",
        "ref_url": "https://mct.aacrjournals.org/content/15/2/251"
      },
      {
        "ref_id": "31164456",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/31164456"
      },
      {
        "ref_id": "31771279",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/31771279"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4650290",
    "parent_molecule_chembl_id": "CHEMBL4650290",
    "record_id": 3490067,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 8684,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "32414908",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/32414908/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4297774",
    "parent_molecule_chembl_id": "CHEMBL4297774",
    "record_id": 3133400,
    "selectivity_comment": "Including exon 20 deletions, C797S, T790M",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "VACCINE ANTIGEN",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 8760,
    "mechanism_comment": "Cancer vaccine",
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 vaccine antigen",
    "mechanism_refs": [
      {
        "ref_id": "28274144",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/28274144/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL2107863",
    "parent_molecule_chembl_id": "CHEMBL2107863",
    "record_id": 1695943,
    "selectivity_comment": "Targets the EGFRvIII mutation site",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 9098,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "label/2021/215310s000lbl.pdf",
        "ref_type": "FDA",
        "ref_url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215310s000lbl.pdf"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4650319",
    "parent_molecule_chembl_id": "CHEMBL4650319",
    "record_id": 3490097,
    "selectivity_comment": "Inhibits EGFR exon 20 insertion mutants at lower concentrations than wild type. Also inhibits HER2, HER4 and BLK kinases.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "ANTAGONIST",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 9128,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 antagonist",
    "mechanism_refs": [
      {
        "ref_id": "29423521",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/29423521/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3989988",
    "parent_molecule_chembl_id": "CHEMBL3989988",
    "record_id": 2973346,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 9248,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "34028784",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/34028784/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4558324",
    "parent_molecule_chembl_id": "CHEMBL4558324",
    "record_id": 3460881,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "T790M",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 9249,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "34028784",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/34028784/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4558324",
    "parent_molecule_chembl_id": "CHEMBL4558324",
    "record_id": 3460881,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "L858R",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 9356,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "33713216",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/33713216/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4594549",
    "parent_molecule_chembl_id": "CHEMBL4594549",
    "record_id": 3461220,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 9501,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "34025638",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/34025638/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4594472",
    "parent_molecule_chembl_id": "CHEMBL4594472",
    "record_id": 3461142,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 9502,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "label/2021/215310s000lbl.pdf",
        "ref_type": "FDA",
        "ref_url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215310s000lbl.pdf"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4802239",
    "parent_molecule_chembl_id": "CHEMBL4650319",
    "record_id": 3841356,
    "selectivity_comment": "Inhibits EGFR exon 20 insertion mutants at lower concentrations than wild type. Also inhibits HER2, HER4 and BLK kinases.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 9503,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "34028784",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/34028784/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4558324",
    "parent_molecule_chembl_id": "CHEMBL4558324",
    "record_id": 3460881,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 3,
    "mec_id": 9632,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "20068188",
        "ref_type": "PubMed",
        "ref_url": "http://europepmc.org/abstract/MED/20068188"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3989988",
    "parent_molecule_chembl_id": "CHEMBL3989988",
    "record_id": 2973346,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 10020,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "label/2024/219008s000lbl.pdf",
        "ref_type": "FDA",
        "ref_url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/219008s000lbl.pdf"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL6068478",
    "parent_molecule_chembl_id": "CHEMBL4558324",
    "record_id": 4658917,
    "selectivity_comment": "Inhibits EGFR exon 19 deletions at lower concentrations than wildtype EGFR.",
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 4,
    "mec_id": 10021,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor erbB1 inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "label/2024/219008s000lbl.pdf",
        "ref_type": "FDA",
        "ref_url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/219008s000lbl.pdf"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL6068478",
    "parent_molecule_chembl_id": "CHEMBL4558324",
    "record_id": 4658917,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "L858R",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  },
  {
    "action_type": "BINDING AGENT",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 10087,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor binding agent",
    "mechanism_refs": [
      {
        "ref_id": "32189093",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/32189093/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL4594515",
    "parent_molecule_chembl_id": "CHEMBL4594515",
    "record_id": 3461186,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": null
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 10110,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "31954624",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/31954624/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3787344",
    "parent_molecule_chembl_id": "CHEMBL3787344",
    "record_id": 2473324,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": null,
      "isoform": null,
      "mutation": "UNDEFINED MUTATION",
      "organism": null,
      "sequence": "",
      "tax_id": null,
      "version": null
    }
  },
  {
    "action_type": "INHIBITOR",
    "binding_site_comment": null,
    "direct_interaction": 1,
    "disease_efficacy": 1,
    "max_phase": 2,
    "mec_id": 10111,
    "mechanism_comment": null,
    "mechanism_of_action": "Epidermal growth factor receptor inhibitor",
    "mechanism_refs": [
      {
        "ref_id": "31954624",
        "ref_type": "PubMed",
        "ref_url": "https://pubmed.ncbi.nlm.nih.gov/31954624/"
      }
    ],
    "molecular_mechanism": 1,
    "molecule_chembl_id": "CHEMBL3787344",
    "parent_molecule_chembl_id": "CHEMBL3787344",
    "record_id": 2473324,
    "selectivity_comment": null,
    "site_id": null,
    "target_chembl_id": "CHEMBL203",
    "variant_sequence": {
      "accession": "P00533",
      "isoform": 1,
      "mutation": "L858R",
      "organism": "Homo sapiens",
      "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
      "tax_id": 9606,
      "version": 2
    }
  }
]